Skip to main content

Month: March 2025

Teknova Reports Fourth Quarter and Full Year 2024 Financial Results

Full year 2024 total revenue was $37.7 million, up 3% year-over-year and in line with guidanceFourth quarter 2024 total revenue was $9.3 million, up 18% over the same quarter prior yearCompany provides 2025 revenue guidance of $39-42 million HOLLISTER, Calif., March 04, 2025 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results for the fourth quarter and full year ended December 31, 2024. “I am very proud of our execution in 2024, across-the-board,” said Stephen Gunstream, President and Chief Executive Officer at Teknova. “We brought in new clinical customers, improved operational efficiency, and managed expenses while,...

Continue reading

Gulf Island Reports Fourth Quarter and Full Year 2024 Results

THE WOODLANDS, Texas, March 04, 2025 (GLOBE NEWSWIRE) — Gulf Island Fabrication, Inc. (NASDAQ: GIFI) (“Gulf Island” or the “Company”), a leading steel fabricator and service provider to the industrial and energy sectors, today announced its results for the fourth quarter and full year 2024. FOURTH QUARTER 2024 SUMMARYConsolidated revenue of $37.4 million; Adjusted consolidated revenue of $37.3 million Consolidated net income of $4.3 million; Adjusted consolidated EBITDA of $3.7 million Services division operating income of $0.9 million; EBITDA of $1.4 million Fabrication division operating income of $4.0 million; EBITDA of $4.6 million Cash and short-term investments balance of $67.3 million at December 31, 2024FULL YEAR 2024 SUMMARYConsolidated revenue of $159.2 million; Adjusted consolidated revenue of $158.1 million Consolidated...

Continue reading

Orion Group Holdings Reports Fourth Quarter and Full Year 2024 Results

HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) — Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today reported its financial results for the fourth quarter and full year ended December 31, 2024. Highlights for the quarter ended December 31, 2024:Contract revenues increased 7.6% to $216.9 million versus the prior year period GAAP net income of $6.8 million or $0.17 per diluted share compared to a GAAP net loss of $4.4 million or a loss of $0.13 per diluted share year-over-year Adjusted net income of $6.4 million or $0.16 per diluted share versus Adjusted net income of $2.3 million or $0.07 per diluted share in the fourth quarter last year Adjusted EBITDA increased 15.3% to $17.1 million compared to the prior year period Cash flow from operations of $13.4 million Contracted backlog,...

Continue reading

Cricut, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Delivered 8th consecutive year of profitability with net income of $62.8 million, or 8.8% marginNet Income increased 17% or $9.2 million, compared to 2023Generated $265.0 million in Cash from Operations in 2024Paid subscribers increased to 2.96 million, up 7% over FY 2023FY 2024 revenue of $712.5 million, a 7% decline compared to FY 2023 SOUTH JORDAN, Utah, March 04, 2025 (GLOBE NEWSWIRE) — Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced financial results for its fourth quarter and full year ended December 31, 2024. “We have a strong conviction in our category and the overall market potential. While our opportunity is sizeable, even in the shorter term, we are disappointed with our inability to execute...

Continue reading

Weyco Reports Fourth Quarter and Full Year 2024 Results

MILWAUKEE, March 04, 2025 (GLOBE NEWSWIRE) — Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter and year ended December 31, 2024. Fourth Quarter 2024 OverviewNet sales: $80.5 million (flat with Q4 2023) Gross earnings: 47.9% of net sales (down compared to 50.3% of net sales in Q4 2023) Earnings from operations: $11.5 million (flat with Q4 2023) Net earnings: $10.0 million (up 17% compared to $8.5 million in Q4 2023) Diluted earnings per share: $1.04 (up from $0.90 in Q4 2023)North American Wholesale Segment Net sales in our wholesale segment totaled $60.4 million in the fourth quarter of 2024, up 1% compared to $59.6 million in the fourth quarter of 2023. Higher sales of our Florsheim and Nunn Bush brands were mostly offset by lower sales of BOGS and Stacy...

Continue reading

NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

— Record quarterly revenue of $21.5 million in Q4 2024 — — Full-year 2025 revenue guidance of $92 to $96 million — — Completed an underwritten public offering of $74.8 million, using $49.5 million of the net proceeds to repurchase 100% of KCK holdings and $20.2 million to strengthen its balance sheet to support planned operations to reach cash flow breakeven — — Management scheduled to host a conference call today at 4:30 p.m. ET — MOUNTAIN VIEW, Calif., March 04, 2025 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the fourth quarter and full year ended December 31, 2024, and provided a corporate update. Recent HighlightsQuarterly revenue grew 19% year-over-year...

Continue reading

Latham Group, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance

 Latham’s In-Ground Pool Sales Outperformed the U.S. Pool Market in 2024 Driven by Fiberglass Share Gains and Increased Adoption of Automatic Safety Covers Year-on-Year Margin Expansion Reflects Lower Cost Structure and Cost Discipline Amid Ongoing Investments to Drive Future Growth Full Year Operating Cash Flow of $61 Million; Year-End Cash Balance of $56 Million after $86 Million of Acquisition Payments and Debt Paydowns 2025 Guidance Anticipates 8% Sales Growth and 19% Growth in Adjusted EBITDA at the MidpointsFourth Quarter 2024 Financial Highlights:Net sales of $87.3 million Net loss of $29.2 million / Net loss per diluted share of $0.25 Adjusted EBITDA of $3.6 million / 4.2% of Net salesFull Year 2024 Financial Highlights:Net sales of $508.5 million Net loss of $17.9 million / Net loss per diluted share of $0.15 Adjusted...

Continue reading

Flutter Entertainment Reports Fourth Quarter 2024 Financial Results

NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) — Flutter Entertainment (NYSE:FLUT; LSE:FLTR), the world’s leading online sports betting and iGaming operator, announces Q4 and full year 2024 results and introduces 2025 guidance. Key financial highlights:In $ millions except where stated otherwiseThree months ended December 31 Fiscal year ended December 312024   2023   YOY 2024   2023   YOY             Average monthly players (AMPs) (‘000s)1 14,605   13,588   +7 % 13,898   12,325   +13 %Revenue 3,792   3,313   +14 % 14,048   11,790   +19 %Net income (loss) 156   (902 ) +117 % 162   (1,211 ) +113 %Net income (loss) margin 4.1 % (27.2 )% +3,130bps  1.2 % (10.3 )% +1,150bps Adjusted EBITDA2,3 655   632   +4 % 2,357   1,875   +26 %Adjusted EBITDA Margin2 17.3 % 19.1 % (180)bps  16.8 % 15.9 % +90bps Earnings...

Continue reading

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

Record full year 2024 revenue of $204.7 million increased 38% compared to prior year, and more than doubled fourth quarter 2024 adjusted EBITDA WARSAW, Ind., March 04, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 & Recent Business HighlightsHelped a new record of over 34,000 children in the fourth quarter 2024 and approximately 138,000 for full year 2024, bringing the total to over 1.14 million since the inception of OrthoPediatrics          Generated total revenue of $52.7 million for fourth quarter 2024, up 40% from $37.6 million in fourth quarter 2023; domestic...

Continue reading

Eos Energy Enterprises Meets 2024 Revised Revenue Guidance and Reports Fourth Quarter & Full-Year 2024 Financial Results; Reaffirms 2025 Revenue Guidance

Achieved Cerberus third tranche of operational performance milestones and secured final $40.5 million to fully fund $210.5 million Delayed Draw Term Loan Closed $303.5 million loan guaranteed by the U.S. Department of Energy’s Loan Programs Office and secured first funding of $68.3 million Secured $8 million standalone BESS order for Naval Base of San Diego to advance American energy independence Grew customer orders backlog to $682 million, a 28% increase year over year Launched Factory 2 Works with eight states responding to Requests for Proposals and multiple sites now shortlisted Reiterates 2025 full-year revenue guidance range of $150 million – $190 million Strengthened executive leadership, appointed current Chief Financial Officer, Nathan Kroeker to Chief Commercial Officer; welcomed new Chief Financial Officer, Eric Javidi,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.